Skip to Content

BMS 6081 (Metaglip 2.5 mg / 250 mg)

Generic Name: glipizide/metformin

Pill with imprint BMS 6081 is Pink, Elliptical / Oval and has been identified as Metaglip 2.5 mg / 250 mg. It is supplied by Bristol-Myers Squibb.

Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 6081

Metaglip

Generic Name:
glipizide/metformin
Imprint:
BMS 6081
Strength:
2.5 mg / 250 mg
Color:
Pink
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide